Antiglio

Epitopoietic research, anti-cancer fund. This Token is created with the sole purpose of gathering funds that will be used for medical research for the treatment of glioblastoma patients. Funds gathered will be transferred to start-up pharma laboratories and pharma companies that have active research programs against glioblatoma. Companies will pledge shares against funds that will be granded to them. The ecosystem and the price of the token will be backed by these stocks securing the price of the token.